Andrew Morgan

Before joining Genzyme, Mr. Morgan served as the Vice President of Regulatory, Quality, and Pharmaceutical Sciences at Bone Care International in Middleton until the company’s acquisition by Genzyme in 2005. Prior to joining Bone Care, he was the Director of Regulatory Affairs for Celltech Pharmaceuticals, Inc. in Rochester, New York. Before joining Celltech, he was the manager of regulatory affairs for Medeva Pharmaceuticals in Fort Worth, Texas. He has over 25 years of experience helping lead pharmaceutical companies while being responsible for regulatory, quality, development, and manufacturing activities. Andrew currently serves as a Pharmaceutical Catalyst on the Wisconsin Alumni Research Foundation (WARF) Accelerator Program. Mr. Morgan, a registered pharmacist, received his Bachelor of Science of Pharmacy degree from SWOSU School of Pharmacy in Weatherford, Oklahoma.